Cannabis Stocks Jump After President Trump's Pro-CBD Comments
Cannabis company stocks surged by around 20% on Monday after U.S. President Donald Trump posted on social media about the potential health benefits of cannabidiol (CBD) for senior citizens. In his message, President Trump suggested that CBD could help seniors and proposed that Medicare should consider covering CBD products.
Major cannabis companies saw their stock prices rise sharply following the post. Tilray Brands' shares climbed nearly 20%, with even larger gains briefly during the morning. Other companies like Canopy Growth and Cronos Group also experienced double-digit increases.
Although cannabis has become legal for medical use in 40 states and for recreational use in 24 states, federal restrictions continue to limit the industry’s growth. The President’s comments renewed investor hopes that federal policy could become more supportive of cannabis and CBD products in the future.
Stocks rose after President Trump posted on social media about the benefits of CBD for seniors and suggested Medicare should cover CBD products.
CBD, or cannabidiol, is a non-psychoactive compound found in cannabis that some people use for health-related reasons.
No, there has not been any change to federal law. The stock surge happened because of the President’s comments, not a policy change.
Tilray Brands, Canopy Growth, and Cronos Group were some of the biggest gainers.
24/7 Wall Street
Invezz
Reuters
Benzinga
New York Post
CNBC Television
The Guardian
The Motley Fool
Proactive Investors